# Markers and Mechanisms of Vascular Disease in Type II Diabetes

> **NCT00256646** · — · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 298 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00256646
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2014-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256646, "Markers and Mechanisms of Vascular Disease in Type II Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00256646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*